The 20 Best NUT Carcinoma Doctors in The United States

Stephen Sallan is a Pediatrics provider practicing medicine in Boston, Massachusetts. Dr. Sallan is rated as an Elite provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses NUT Carcinoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Adult T-Cell Leukemia. Dr. Sallan is board certified in Pediatrics.

Steven Dubois is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Dubois is rated as an Elite provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Ewing Sarcoma, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Osteosarcoma.

James Bradner is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Bradner is rated as an Elite provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses NUT Carcinoma, Leukemia, Acute Lymphoblastic Leukemia (ALL), and Acute Myeloid Leukemia (AML).

Glenn Hanna is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Hanna is rated as an Elite provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Merkel Cell Carcinoma, and NUT Carcinoma.

Daniel Bauer is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Bauer is rated as an Elite provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses NUT Carcinoma, Sickle Cell Disease, Beta Thalassemia, Hemoglobinopathy, and Bone Marrow Transplant.

Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is rated as a Distinguished provider by MediFind in the treatment of NUT Carcinoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is board certified in American Board Of Internal Medicine.

Renata Ferrarotto is an Oncologist practicing medicine in Cary, North Carolina. Dr. Ferrarotto is rated as a Distinguished provider by MediFind in the treatment of NUT Carcinoma. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Adenoid Cystic Carcinoma, Anaplastic Thyroid Cancer, Olfactory Neuroblastoma, Thyroidectomy, and Gastrostomy.

Paolo Caimi is a Hematologist Oncology specialist and a Hematologist practicing medicine in Cleveland, Ohio. Dr. Caimi is rated as an Advanced provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Caimi is board certified in American Board Of Internal Medicine, 2011.

Carlos Rodriguez is a Hematologist and an Oncologist practicing medicine in Memphis, Tennessee. Dr. Rodriguez is rated as a Distinguished provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Germ Cell Tumor, Retinoblastoma, Langerhans Cell Histiocytosis, Hepatectomy, and Tissue Biopsy.

Shodeinde Coker is a Hematologist practicing medicine in Towson, Maryland. Dr. Coker is rated as a Distinguished provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses NUT Carcinoma, Myelofibrosis, and Thrombocytopenia.

Jared Weiss is an Otolaryngologist practicing medicine in Chapel Hill, North Carolina. Dr. Weiss is rated as a Distinguished provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Small Cell Lung Cancer (SCLC), Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).

Kimberly Stegmaier is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Stegmaier is rated as a Distinguished provider by MediFind in the treatment of NUT Carcinoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, Leukemia, and Neuroblastoma.

Ruby Gupta is a Hematologist and an Oncologist practicing medicine in Dearborn, Michigan. She has been practicing medicine for over 21 years. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of NUT Carcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Anemia, Acute Mountain Sickness, Iron Deficiency Anemia, and NUT Carcinoma. Dr. Gupta is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine.

Charles Reninger, MD, specializes in hematology oncology and is board-certified in medical oncology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center - Pinnacle and is affiliated with UPMC Memorial, UPMC Lititz, UPMC Hanover, UPMC Carlisle, UPMC West Shore, UPMC Community Osteopathic, and UPMC Harrisburg. Dr. Reninger received his medical degree from the Medical College of Pennsylvania and completed his residency program at the Hospital of the University of Pennsylvania, followed by a fellowship program at the University of Florida College of Medicine. Dr. Reninger is rated as an Experienced provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Lung Cancer, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Reninger is currently accepting new patients.

Michael Stender is a Hematologist and a Palliative Medicine provider practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 34 years. Dr. Stender is rated as an Experienced provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Childhood Iron Deficiency Anemia, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Stender is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Stender is currently accepting new patients.

Matteo Trucco is a Hematologist and an Oncologist practicing medicine in San Marcos, California. Dr. Trucco is rated as an Advanced provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Ewing Sarcoma, Adult Soft Tissue Sarcoma, and NUT Carcinoma.

Seerin Shatavi is a Hematologist and an Oncologist practicing medicine in Cincinnati, Ohio. She has been practicing medicine for over 24 years. Dr. Shatavi is rated as an Advanced provider by MediFind in the treatment of NUT Carcinoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, NUT Carcinoma, and Iron Deficiency Anemia. Dr. Shatavi is board certified in American Board Of Internal Medicine - 2016 and American Board Of Internal Medicine - 2017. Dr. Shatavi is currently accepting new patients.

Bach Ardalan is a Hematologist practicing medicine in Miami, Florida. Dr. Ardalan is rated as an Advanced provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Familial Colorectal Cancer, and Stomach Cancer.

Jennifer Tseng, MD, hematologist/medical oncologist, is the Thoracic/Head and Neck Specialty Section leader for Medical Oncology and the associate director of Clinical Research for Medical Oncology at Orlando Health Cancer Institute.Dr. Tseng received her medical degree from Duke University School of Medicine. She completed her residency and served as assistant chief resident in internal medicine at Duke University Medical Center. She completed a fellowship in medical oncology and hematology at The University of Texas MD Anderson Cancer Center in Houston. She is board-certified in internal medicine and medical oncology and board-eligible in hematology. Dr. Tseng has received several honors and awards, including the C.D. Howe Award for clinical excellence in medical oncology and a Clinical Research Award from MD Anderson, the American Medical Women's Award, Hewlett Packard Award, the Alpha Omega Alpha Research Symposium Award from Duke University and a Beneficial-Hodgson scholarship from The Johns Hopkins University. She was also awarded Attending of the Year from the Internal Medicine Residency Program from Orlando Regional Medical Center and received the Exemplary Physician Colleague Award from Orlando Health in 2009.In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer and novel agents in the treatment of head and neck cancer. She has recently presented at the Annual Thoracic Oncology Symposium of the Puerto Rican Society of Hematology Oncology and spoke on neoadjuvant and adjuvant treatment strategies in lung cancer. Dr. Tseng is rated as an Advanced provider by MediFind in the treatment of NUT Carcinoma. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Tseng is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.

Matthew Hemming is an Oncologist practicing medicine in Worcester, Massachusetts. He has been practicing medicine for over 14 years. Dr. Hemming is rated as an Advanced provider by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Gastrointestinal Stromal Tumor, Adult Soft Tissue Sarcoma, Alveolar Soft Part Sarcoma, and Mesenchymoma. Dr. Hemming is board certified in Internal Medicine and Medical Oncology.